Related Experiment Video

Updated: Jun 1, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
09:41

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract

Published on: June 17, 2014

High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression

Junxia Zhang1, Kai Huang, Zhendong Shi

  • 1Department of Neurosurgery, Tianjin Medical University General Hospital, Laboratory of Neuro-Oncology, Tianjin Neurological Institute, Tianjin 300052, China.

Neuro-Oncology
|June 4, 2011
PubMed

Insights

The beta-catenin/Tcf-4 pathway drives glioma progression by increasing Tcf-4 and AKT2 levels. Inhibiting this pathway reduces tumor growth, invasion, and proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • The beta-catenin/Tcf-4 signaling pathway is implicated in human cancer.
  • The precise mechanisms of this pathway in tumorigenesis remain unclear.

Purpose of the Study:

  • To investigate the role of the beta-catenin/Tcf-4 pathway in glioma progression.
  • To identify downstream targets of this pathway in gliomas.

Main Methods:

  • Quantification of Tcf-4 and AKT2 protein levels in glioma tissues.
  • In vitro and in vivo experiments to assess the impact of pathway inhibition on glioma cells.
  • Chromatin immunoprecipitation and luciferase reporter assays to validate gene promoter binding.

Main Results:

  • Tcf-4 protein levels were significantly elevated in high-grade gliomas compared to low-grade gliomas.
  • Tcf-4 levels positively correlated with AKT2 levels.
  • Inhibition of beta-catenin/Tcf-4 activity reduced glioma cell proliferation, invasion, and tumor growth.
  • AKT2 was identified as a direct target gene regulated by beta-catenin/Tcf-4.

Conclusions:

  • Tcf-4 is associated with glioma progression.
  • AKT2 is a novel downstream target of the beta-catenin/Tcf-4 pathway in gliomas.
  • Targeting the beta-catenin/Tcf-4/AKT2 axis may offer therapeutic strategies for gliomas.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...